title: Does a "thiol shield" protect tumors from natural IgM antibody, and, if so, how can it be suppressed?
abstract: Natural anti-tumor IgM antibodies are prevalent in the serum of cancer patients and normal subjects. Extensive research has been directed toward the ultimate goal of achieving a therapeutic effect from these antibodies either augmented by vaccination or by passive infusion. To date, the therapeutic effects have been limited. This thesis asserts that thiols within solid tumors reduce pentameric IgM to monomeric or other subunit form resulting in inactivation of its complement fixing and cross linking apoptosis inducing properties. A rationale for this normal physiological inactivation mechanism, possibly necessary for wound healing and pregnancy, is proposed along with therapeutic approaches, which would potentially suppress IgM inactivation.
authors: jpude@msn.com
authors: Peter C
authors: PC
authors: Jones
mesh_terms: D000818:Animals; D000912:Antibodies, Neoplasm / Q000276:immunology*; D017209:Apoptosis / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology*; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology* / Q000473:pathology; D013438:Sulfhydryl Compounds / Q000276:immunology*
chemical_list: D000912:Antibodies, Neoplasm; D007075:Immunoglobulin M; D013438:Sulfhydryl Compounds